Instituto de Investigación Marqués de Valdecilla

Running trials

• Recruiting

  A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

  2025-523670-17-00· Phase 3· Source

• Active, not recruiting

  A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

  NCT06447168· Source

• Recruiting

  Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients

  NCT05817903· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Kidney cancer1 recruiting
• Lupus (SLE)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study With CIT-013 in RA Patients

  NCT06567470· Phase 2· Source

Trial sites

• Instituto De Investigacion Marques De Valdecilla3 trials
• Instituto De Investigacion Marques De Valdecilla (IDIVAL)1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Crohn's disease29 works · 0 trials
• Fatty liver disease (MASLD/MASH)26 works · 0 trials
• Lupus (SLE)22 works · 1 trials
• Primary biliary cholangitis4 works · 1 trials